{"lastClose": 1.1100000143051147, "len": 492, "date": "2023-03-02", "alpha_1": -0.8881021327597577, "beta_1": 0.1548127846689945, "drawup_1": 0.7325581218050006, "natr_1": 33.038226379078544, "sup_1": -0.011711703971477186, "res_1": 0.2819819814982172, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD"], "rsi_1": 59.11885181452432, "adx_1": 22.782729191103613, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.5687470729877948, "stratHoldAlpha_1": 249.87073904190885, "stratHoldDrawdown_1": -0.8349982823952652, "alpha_3mo": 1.2973266955873126, "beta_3mo": -0.218228643970871, "drawup_3mo": 0.4117647223819081, "sharpe_3mo": -0.6057449308941412, "natr_3mo": 33.038226379078544, "sup_3mo": -0.1801802208164118, "res_3mo": 0.009009000301245093, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD", "ENGULFING"], "rsi_3mo": 39.02438527980313, "adx_3mo": 72.07826222969891, "drawdown_3mo": -0.30894308076342014, "stratHoldSharpe_3mo": -0.37126276507819356, "stratHoldAlpha_3mo": 250.77938521016412, "stratHoldDrawdown_3mo": -0.27804877268707817, "Market Cap": 288077598, "Country": "Cayman Islands", "Name": "LumiraDx Limited", "Sector": "Health Care", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "alpha%_1": 0.0036485876827644435, "beta%_1": 0.05391112758113213, "drawup%_1": 0.6889850604477228, "natr%_1": 1.0, "drawdown%_1": 0.0032719784027626098, "stratHoldSharpe%_1": 0.013701603429813502, "stratHoldAlpha%_1": 3.959068574330689e-06, "stratHoldDrawdown%_1": 0.002878005088609397, "alpha%_3mo": 0.7618442904163664, "beta%_3mo": 0.022529821027725466, "drawup%_3mo": 0.82070640487677, "sharpe%_3mo": 0.12514855774175432, "natr%_3mo": 1.0, "drawdown%_3mo": 0.02598930764435096, "stratHoldSharpe%_3mo": 0.2709256720009451, "stratHoldAlpha%_3mo": 0.21774198513857235, "stratHoldDrawdown%_3mo": 0.0282730714627098}